HIT · Health In Tech
AI read · Neutral
The AI's read
HIT missed Q2 GAAP revenue at $8.1M (down from $9.3M) and posted a negative adjusted EBITDA of $1.3M, yet management pointed to $32.3M of contracted revenue and a $66.3M pipeline. The company also reaffirmed full-year guidance and grew distribution partners 19.9% YoY, so there is obvious optionality in H2. The market sold the print hard, down ~8.8% intraday, implying near-term skepticism about timing and execution. Our take: mixed signals until contracted revenue actually converts and carrier onboarding timing proves out, so we’d wait for H2 evidence or clearer cadence on policy effective dates.